Loading…
Cerus Corporation is projected to rise to $3.60 by 2027, a +28% move from its current price of $2.82. CERS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.72 | $2.82 | $2.92 | -0.02% |
| May 30 | $2.68 | $2.82 | $2.96 | -0.04% |
| May 31 | $2.65 | $2.82 | $2.99 | -0.06% |
| Jun 1 | $2.63 | $2.82 | $3.02 | -0.09% |
| Jun 2 | $2.61 | $2.82 | $3.04 | -0.11% |
| Jun 3 | $2.59 | $2.82 | $3.07 | -0.13% |
| Jun 4 | $2.57 | $2.82 | $3.09 | -0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.57 | $2.82 | $3.09 | -0.15% |
| Week 2 | $2.47 | $2.81 | $3.20 | -0.30% |
| Week 3 | $2.39 | $2.81 | $3.29 | -0.45% |
| Week 4 | $2.33 | $2.80 | $3.37 | -0.60% |
| Week 5 | $2.28 | $2.80 | $3.44 | -0.74% |
| Week 6 | $2.23 | $2.79 | $3.50 | -0.89% |
| Week 7 | $2.19 | $2.79 | $3.56 | -1.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cerus Corporation operates as a healthcare company in the biomedical products space. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
INTERCEPT Blood System is a proprietary technology for controlling biological replication designed to reduce blood-borne pathogens in donated blood components intended for transfusion. It also offers INTERCEPT Blood Systems for platelets, plasma, and cryoprecipitation, as well as INTERCEPT Illuminator, an LED-based device for blood component treatment.
Cerus sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. It was incorporated in 1991 and is headquartered in Concord, California.
Cerus Corporation is a healthcare stock currently priced at $2.71 per share with a market cap of $543M, and it ranks 2977.
The 30-day price range is $2.13 to $3.44.
Forecasts show a path of upside over the long term, with the average price moving from $2.71 in 2026 to $5.11 in 2030 and $19.20 in 2050, and with max values reaching $7.95 in 2030, $22.69 in 2040, and $39.88 in 2050. The implied ROI climbs to 88.5 by 2030, 348.4 by 2040, and 608.4 by 2050, with sentiment turning bullish from 2027 onward.
A major floor 43.5% below — a decisive break under it would weaken the trend.
The nearest floor, 32.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 21.7% above — clearing it would confirm fresh momentum.
Key CERS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CERS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.74 | Buy | $2.73 | Buy |
| MA 10 | $2.63 | Buy | $2.66 | Buy |
| MA 20 | $2.56 | Buy | $2.53 | Buy |
| MA 50 | $2.15 | Buy | $2.31 | Buy |
| MA 100 | $2.21 | Buy | $2.17 | Buy |
| MA 200 | $1.90 | Buy | $2.00 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.96 | Neutral |
| Stoch RSI (14) | 83.10 | Sell |
| CCI (20) | 110.10 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 8.05 | Buy |
| Bollinger %B (20,2) | 0.79 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.06 | Buy |
| Awesome (5,34) | 0.42 | Buy |
| Ultimate (7,14,28) | 80.22 | Sell |
| Momentum (10) | 0.27 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 2.81 | Buy |
| ADX (14) | 25.87 | Buy |
| ATR (14) | 0.08 | Info |
The 30-day technical picture shows momentum and key levels.
RSI14 is 60, indicating neutral-bullish momentum for the near term. Price is above both the SMA50 ($2.11) and the SMA200 ($1.88), suggesting a mildly bullish short-term tilt.
Support sits at $1.90 and resistance at $2.74, while the 30-day price range runs from $2.13 to $3.44.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.69 | $2.82 | $3.67 | 0% | Neutral | |
| $2.78 | $3.60 | $4.98 | +28% | Bullish | |
| $3.30 | $4.43 | $6.41 | +57% | Bullish | |
| $3.55 | $4.91 | $7.34 | +74% | Bullish | |
| $3.67 | $5.21 | $8.02 | +85% | Bullish | |
| $3.32 | $4.83 | $7.62 | +71% | Bullish | |
| $3.66 | $5.45 | $8.81 | +93% | Bullish | |
| $4.34 | $6.62 | $10.91 | +135% | Bullish | |
| $4.68 | $7.27 | $12.21 | +158% | Bullish | |
| $5.32 | $8.45 | $14.43 | +200% | Bullish | |
| $6.84 | $11.92 | $21.89 | +323% | Bullish | |
| $9.19 | $18.92 | $38.57 | +571% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.69 | $2.82 | $3.34 | +0.00% |
| June 2026 | $2.41 | $2.85 | $3.45 | +0.92% |
| July 2026 | $2.32 | $2.77 | $3.41 | -2.82% |
| August 2026 | $2.35 | $2.83 | $3.54 | +2.46% |
| September 2026 | $2.41 | $2.93 | $3.70 | +3.29% |
| October 2026 | $2.32 | $2.83 | $3.61 | -3.28% |
| November 2026 | $2.24 | $2.74 | $3.53 | -3.07% |
| December 2026 | $2.29 | $2.83 | $3.67 | +3.22% |
Click any year to see its month-by-month CERS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CERS to range from $1.69 to $3.67 through 2026. The $2.82 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CERS price prediction for 2027 points to an average of $3.60 (low $2.78, high $4.98) — a potential gain of +28% on today's $2.82. Buyers look set to stay in control over this stretch.
In 2028, CERS is projected to trade between $3.30 and $6.41, averaging $4.43 — a potential gain of +57% from today's $2.82. That is up +23% on the projected 2027 average. Momentum favours further upside here.
Cerus Corporation's 2029 outlook centres on $4.91, within a $3.55 to $7.34 range. That is up +11% on the projected 2028 average. That marks a +74% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CERS could reach as high as $8.02, with a base case around $5.21 and support toward $3.67 — roughly +85% from $2.82. Momentum favours further upside here.
Expect CERS to range from $3.32 to $7.62 through 2031. The $4.83 average target implies a +71% move from current prices. That is -7% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The CERS price prediction for 2032 points to an average of $5.45 (low $3.66, high $8.81) — a potential gain of +93% on today's $2.82. Momentum favours further upside here.
In 2033, CERS is projected to trade between $4.34 and $10.91, averaging $6.62 — a potential gain of +135% from today's $2.82. That is up +21% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Cerus Corporation's 2034 outlook centres on $7.27, within a $4.68 to $12.21 range. That is up +10% on the projected 2033 average. That marks a +158% change versus current levels. Momentum favours further upside here.
By 2035, CERS could reach as high as $14.43, with a base case around $8.45 and support toward $5.32 — roughly +200% from $2.82. Buyers look set to stay in control over this stretch.
Expect CERS to range from $6.84 to $21.89 through 2040. The $11.92 average target implies a +323% move from current prices. That is up +41% on the projected 2035 average. Momentum favours further upside here.
The CERS price prediction for 2050 points to an average of $18.92 (low $9.19, high $38.57) — a potential gain of +571% on today's $2.82. Buyers look set to stay in control over this stretch.
Investing $1,000 in CERS today (≈ 354.609929 CERS) could be worth
$6,710.48
+$5,710.48 (+571%) by 2050 · US Dollar
Based on the average projected CERS price of $18.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CERSwould be worth at today's price.
$1,000 invested in CERS on May 27, 2025 (≈ 793.6508 CERS) would be worth
$2,238.1
+$1,238.1 (+123.8%) today · 2.24× · US Dollar
Based on a CERS entry price of $1.26 vs. today's $2.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.69 | $1,048.33 | +4.8% |
| 1 month ago | $1.98 | $1,424.24 | +42.4% |
| 3 months ago | $2.6 | $1,084.62 | +8.5% |
| 6 months ago | $1.76 | $1,602.27 | +60.2% |
| 1 year ago | $1.26 | $2,238.1 | +123.8% |
| All time (5.0y) ago | $5.72 | $493.01 | -50.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CERS forecast.
Our base-case forecast reaches $5.60 around 2033.
Implied market cap at $5.60: $1.12B
The multi-year forecast paints a bullish trajectory after 2026, with 2026 labeled neutral and subsequent years showing steady upside. By 2030, the average price is $5.11 with an 88.5 ROI and bullish sentiment; by 2040, the average price rises to $12.15 with a 348.4 ROI and bullish sentiment; by 2050, the average price reaches $19.20 with a 608.4 ROI and bullish sentiment.
These figures imply meaningful long-term upside despite near-term uncertainty. The forecast also shows higher potential highs across the horizon, with max values climbing from $7.95 in 2030 to $39.88 in 2050. Downside risk and volatility are acknowledged, and these are estimates, not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $5.11 with a min of $3.56 and a max of $7.95, and an ROI of 88.5, with bullish sentiment.
The forecast for 2027 onward shows bullish sentiment with rising averages (e.g., 2027 avg $3.51, 2028 avg $4.39, 2029 avg $4.86) and increasing ROI (29.4 in 2027, 61.9 in 2028, 79.2 in 2029, culminating at 88.5 in 2030). These are estimates, not guarantees.
Yes. The forecast max prices include $11.02 in 2033 and $12.43 in 2034, with $22.69 max in 2040, indicating potential to exceed $10 in the mid-2020s to 2040 horizon.
Current price is $2.71 and market cap is $543M, with a rank of 2977.
The 30-day range is $2.13 to $3.44.
Cerus Corporation Community Discussion
0Share your Cerus Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.